Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Abud-Mendoza

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Reumatologia Clinica|May 22, 2012
Medical ethics, research and the pharmaceutical industryCarlos Abud-Mendoza
Reumatologia Clinica|March 8, 2013
Lupus nephritis: advances in the knowledge of its immunopathogenesis without the expected therapeutic success?Carlos Abud-Mendoza
Annals of the Rheumatic Diseases|October 11, 2017
Statins in systemic lupus erythematosusCarlos Abud-Mendoza
Reumatologia Clinica|April 11, 2013
IgG4 (IgG4-RD) related diseases, with a horizon not limited to Mikulicz's diseaseCarlos Abud-Mendoza
The Journal of Rheumatology|December 3, 2017
Comorbidities of Inflammatory Arthropathies in the Art of Diego VelázquezDolores Ramos-Bello, Carlos Abud-Mendoza
Lupus|June 8, 2022
Standard glucocorticoid doses in children with lupus nephritis. Are they convenient?Alexander Velázquez-Guevara, Carlos Abud-Mendoza
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 2, 2014
[Interstitial lung disease (ILD) in rheumatoid arthritis (RA)]Carlos Abud-Mendoza, Enrique Cuevas-Orta
Annals of the Rheumatic Diseases|August 15, 2013
Are steroids required for induction therapy and relapses in lupus nephritis?Carlos Abud-Mendoza, Roberto González-Amaro
Annals of the Rheumatic Diseases|November 7, 2020
Correspondence on 'Tapering towards DMARD-free remission in rheumatoid arthritis'Iveth Eunice García, Carlos Abud-Mendoza
Reumatologia Clinica|June 11, 2013
Neuropsychiatric manifestations in systemic lupus erythematosus: physiopathogenic and therapeutic basisGeorgina Aguilera-Pickens, Carlos Abud-Mendoza
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Reumatologia Clinica|May 22, 2012
Medical ethics, research and the pharmaceutical industryCarlos Abud-Mendoza
Reumatologia Clinica|March 8, 2013
Lupus nephritis: advances in the knowledge of its immunopathogenesis without the expected therapeutic success?Carlos Abud-Mendoza
Annals of the Rheumatic Diseases|October 11, 2017
Statins in systemic lupus erythematosusCarlos Abud-Mendoza
Reumatologia Clinica|April 11, 2013
IgG4 (IgG4-RD) related diseases, with a horizon not limited to Mikulicz's diseaseCarlos Abud-Mendoza
The Journal of Rheumatology|December 3, 2017
Comorbidities of Inflammatory Arthropathies in the Art of Diego VelázquezDolores Ramos-Bello, Carlos Abud-Mendoza
Lupus|June 8, 2022
Standard glucocorticoid doses in children with lupus nephritis. Are they convenient?Alexander Velázquez-Guevara, Carlos Abud-Mendoza
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 2, 2014
[Interstitial lung disease (ILD) in rheumatoid arthritis (RA)]Carlos Abud-Mendoza, Enrique Cuevas-Orta
Annals of the Rheumatic Diseases|August 15, 2013
Are steroids required for induction therapy and relapses in lupus nephritis?Carlos Abud-Mendoza, Roberto González-Amaro
Annals of the Rheumatic Diseases|November 7, 2020
Correspondence on 'Tapering towards DMARD-free remission in rheumatoid arthritis'Iveth Eunice García, Carlos Abud-Mendoza
Reumatologia Clinica|June 11, 2013
Neuropsychiatric manifestations in systemic lupus erythematosus: physiopathogenic and therapeutic basisGeorgina Aguilera-Pickens, Carlos Abud-Mendoza
Pageof 11